Secrets of Natural Healing

The Authoritative Guide to Vaccine Legal Exemptions

Monday, January 24, 2011

Government Goes Into the Drug Research and Development Business; Taxpayers Get the Shaft

What's truly galling about this story from our good friends at Natural News is that U.S. taxpayers -- that's you and me, folks -- will now foot the bill for new drug research and development...

...the new drugs will then be turned over to the pharmaceutical companies by the government...

...and the pharmaceutical companies will charge us for the drugs our taxpayer dollars paid to discover and develop for them in the first place.

So the pharma companies will get virtually free research and development, compliments of the U.S. taxpayer. And the taxpayer gets the shaft from Big Pharma afterwards.

Sweet deal, huh?

Could you imagine the hue and cry from Big Pharma were the federal government to announce they're going to fund new research and development designed to bring new nutritional supplements to market?

-- Spencer

The U.S. government has decided to enter the pharmaceutical business.

Apparently, the drug companies aren't coming out with new "breakthrough" drugs quickly enough, and now the U.S. government plans to spend taxpayer dollars conducting research on drugs which will be turned over to Big Pharma.

Those drug companies, in turn, will sell them for a profit.

It's yet another clear case where the government is taking over the health care (sick care) industry and funneling profits into the hands of pharmaceutical corporations.

This is all happening because drug companies say they're scaling back their research funding to find new drugs.

This terrifies the U.S. government, apparently, which doesn't recognize that scaling back drug company R&D is actually a good thing for America given how much economic damage and personal health damage is caused each year by Big Pharma's dangerous drugs.

So instead of letting the failing pharmaceutical market contract on its own, Big Government wants to artificially prop it up with taxpayer dollars in much the same way that the feds bailed out Wall Street's rich banksters with trillions of dollars over the last two years.

The new government drug research center will operate under the National Institutes of Health (NIH) and be called the National Center for Advancing Translational Sciences.

Dr. Francis Collins, director of the National Institutes of Health, says he hopes Congress will increase funding of the center to at least $1 billion annually.

The NIH, of course, is a revolving door for Big Pharma executives. Dr William Potter, for example, was formerly a researcher at the National Institute of Mental Health, after which he became the vice president of translational neuroscience at Merck.

And the government money that goes into these so-called drug "discoveries" will only end up boosting the profits of drug companies rather than fundamentally improving the health of the American people. (More drugs does not equal better health. If anything it's an inverse correlation: More drugs = more degenerative disease!)

The myth of drug research

Of course, the bigger issue here concerns the mythology of drug development.

The idea that every disease can be treated with a patented synthetic chemical is increasingly being revealed as absurd from the outset.

The highly corrupt cancer industry has been promising a "cure" for cancer since the 1960's... if only they could have another few billion dollars in funding. And yet, year after year, their promises turn out to be yet another fundraising hoax. The whole scheme has now devolved into grotesque absurdity with pink products flooding store shelves backed by the ludicrous idea that "we can all cure cancer by going shopping."

At the same time, the chemical "discoveries" made by the drug companies are so dangerous that they must be approved by the FDA with advisory panels stacked with on-the-take "experts" who are paid by the drug companies, then marketed to the public through extremely manipulative and scientifically dishonest drug advertisements that downplay risks and exaggerate drug benefits.

Even the clinical trials conducted in an attempt to prove the safety of drugs are riddled with lies, fraud and outright corruption.

If Big Pharma's drugs actually worked well, they wouldn't need to rely on such dishonest tactics to convince doctors and patients to use them, it would seem.

The truth is that even Big Pharma's "blockbuster" drugs are outright failures from a human health perspective.

Statin drugs, for example, have been overhyped to such an extreme that doctors are actually recommending they be dripped into the water supply. Yet a rational look at the drugs reveals that they cause extremely dangerous and even deadly side effects such as kidney failure, liver dysfunction, extreme muscle weakness (among other disastrous effects).

Instead of putting more money into "miracle" synthetic drug chemicals, the U.S. government would be far wiser to spend money researching and documenting the healing effects of medicinal plants and foods which are readily available without a prescription (and need no FDA approval).

But of course, the U.S. government isn't interests in supporting the health of the American people. If it was, it wouldn't continue to protect Big Pharma with an FDA monopoly that outlaws natural alternatives that work better, safer and more affordably to prevent and even cure degenerative disease.

So get ready for a government-run pharmaceutical company to enter the picture. I've always said that the U.S. government is merely the marketing branch of Big Pharma. Now it is the research arm, too.

Learn more: http://www.naturalnews.com/031092_government_drug_research.html#ixzz1C0grKLve

Prefer Natural Healing?

The Authoritative Guide to Vaccine Legal Exemptions

From: http://www.dailymail.co.uk/health/article-1348044/Antibiotics-increase-risk-IBS-Crohns-disease-children.html

Tuesday, January 18, 2011

Antibiotics Increase Risk of IBS and Crohn's Disease in Children in Later Life

Research has shown children given penicillin and similar medicines are more at risk from irritable bowel syndrome and Crohn's disease later in life.

Children given antibiotics are twice as likely to develop digestive problems, research shows.

Those prescribed penicillin and similar medicines are more at risk from irritable bowel syndrome (IBS) and Crohn’s disease.

Scientists believe the drugs may encourage harmful bacteria and other organisms to grow in the gut, which trigger the conditions.

A research team looked at 580,000 children over an eight-year period and examined records of their prescriptions and medical history.

The study, published in the journal Gut, showed that children prescribed at least one course of antibiotics by the time they were four were almost twice as likely to have developed IBS.

They were also three and a half times more at risk of Crohn’s disease, an incurable condition which causes abdominal pain, weight loss, nausea and other unpleasant symptoms.

The researchers believe antibiotics destroy ‘good’ bacteria and other tiny organisms known collectively as ‘microflora’ which help protect the gut.

This makes the intestines less tolerant of harmful bacteria, and the person is more susceptible to IBS and similar conditions.

Overall, children aged three or four who had been given antibiotics were 1.84 times more likely to be diagnosed with bowel disease than those never given the drugs.

And the risk of developing the illness increased by 12 per cent every time the medicines were prescribed.

GP Dr George Kassianos said the study means parents will need to be very careful with antibiotics prescribed to children.

Lead researcher Dr Anders Hviid, from the Statens Serum Institute in Copenhagen, Denmark, said:

‘Antibiotics are among the most beneficial discoveries of modern medicine, and decisions regarding their clinical use should be based on very strong evidence. Our study has demonstrated a link, but we cannot conclude that this link is necessarily causal.

‘It might be that the infections that antibiotics are used for increase the risk, or it might be that a third unknown factor associated with infections or antibiotics increase the risk.

‘If antibiotics do cause IBD, we speculate that the effects of antibiotics on the intestinal microflora might be involved.

‘This could involve the removal of beneficial micro-organisms, providing room for pathogenic types or interference with the immune system located in the bowels.’

Researchers found that children were more likely to be prescribed antibiotics if their mothers were young, or had not been to university.

IBS affects between 10 and 20 per cent of Britons, with women twice as likely to suffer from the condition.

Doctors are not sure exactly what causes it but it is often made worse by stress or eating certain foods such as red meat or dairy.

Dr George Kassianos, a GP in Berkshire and a spokesman for the Royal College of General Practitioners, said: ‘We know already that prescribing antibiotics in the first year of life increases the risk of presenting with asthma in early childhood.

‘This study gives us another warning for slightly older children.

'We need to be very careful with antibiotic prescribing in children.

‘What’s more, by quoting studies like this, we may find it easier to persuade parents of the need to avoid antibiotics unless absolutely necessary.’

Helpful Links:

The Authoritative Guide to Vaccine Legal Exemptions

From: http://www.privatemdlabs.com/blood-testing-news/Vitamin_D_Deficiency-Diagnosis_and_Treatment_/Vitamin-D-deficiency-may-be-to-blame-for-chronic-hives--$800346088.php

Will Vitamin D Supplementation Cure Chronic Hives?

People who suffer from chronic hives may benefit from vitamin D testing to see if they have a deficiency.

A new study from University of Nebraska Medical Center researchers has found that there may be a strong connection between the two conditions.

For the study, researchers compared 25 patients with chronic hives against a group of 25 individuals with nasal allergies. They found that the chronic hives group was significantly more likely to have low levels of the nutrient, according to the Associated Press.

While more research is needed to confirm the link between low vitamin D levels, the researchers said that doctors who are treating patients with chronic hives should consider providing them with a vitamin D, according to the news source. This may help them find a potentially simple solution to a problem that can wreak havoc on a patient’s quality of life.

The findings are in keeping with results from others studies that connected low levels of vitamin D to autoimmune conditions. Earlier investigations have shown that deficiencies of the nutrient may lead to difficulty in controlling asthma symptoms.

Helpful Links:

The Authoritative Guide to Vaccine Legal Exemptions

Monday, January 17, 2011

Manufacturing a New "Disease" So You Can More Broadly Market a Drug

Big Pharma manufactures new "diseases" out of thin air by re-defining common character traits as medical conditions. For example, shyness is now referred to by doctors as "Social Anxiety Disorder" or "SAD". This is done so Big Pharma can convince average people they are sick and in need of drugs, and thereby sell billions more dollars worth of prescription pharmaceuticals every year...

If You Prefer Natural Healing...

The Authoritative Guide to Vaccine Legal Exemptions

FDA Warns of Liver Damage from New Heart Rhythm Drug

So...another new drug -- Multaq -- has been found to cause severe toxic liver damage (see article below).

It's only been on the market for a year at this point, and already two people have lost their livers over it.

Question: Isn’t the FDA supposed to make sure drugs that cause severe and permanent damage to the human body don’t get sold to people?

Oh…wait…FDA is too busy drafting plans to regulate nutritional supplements to worry about another Big Pharma drug causing liver damage.

Sorry for asking…

-- Steve

P.S. Er…one more question: Is the FDA banning this toxic drug?

Nope. Just issuing a warning on the label. “Dear Patient, this drug could destroy your liver. Take as recommended. Contact your doctor if you experience signs of liver injury.”

Gee, thanks, FDA. And again, let me get this straight; you’re drafting plans to more heavily regulate…herbs and vitamins?

FDA Warns of Liver Damage from New Heart Rhythm Drug

Federal health officials are warning doctors and patients that a recently launched heart drug from Sanofi-Aventis SA has been linked to liver damage in a handful of patients.

The Food and Drug Administration said Friday it has received several reports of liver damage with Multaq tablets, including two cases in which patients had to have their livers removed. Both patients were women and roughly 70 years old. One had been taking the drug for 4½ months, the other 6 months.

The FDA approved Multaq in July 2009 to treat atrial flutter and atrial fibrillation which are irregular heart rhythms that can reduce blood flow and lead to stroke. More than a half-million prescriptions for Multaq have been written since the drug was approved.

In an online notice, the FDA said it would add a new warning about the risk for liver damage to the label of Multaq. The agency said patients should contact their doctors if they experienced signs of liver injury, including nausea, vomiting or fever. If doctors suspect a toxicity problem, they should discontinue use of the drug and test the patient's liver enzymes.

Liver toxicity is among the most common drug-related side effects across a number of medication classes.

Multaq already carries a black box warning, the most severe type, stating the drug can cause severe complications, including death, in people with recent severe heart failure and should not be used in those patients. Common side effects of the twice-a-day tablets include fatigue, loss of strength, diarrhea, nausea and vomiting.

Paris-based Sanofi reported $84 million in sales for Multaq in the first half of 2009.

Leerink Swann analyst Seamus Fernandez said the safety warning would be unlikely to hurt U.S. sales of drug, which he estimates at $128 million for 2010 and $521 million by 2016.

Sanofi said in a statement it has already issued a letter about the liver injuries to doctors and other health care professionals who prescribe Multaq. The letter recommends prescribers consider giving liver enzyme tests during the first six months of treatment.

"Sanofi-Aventis will continue to be in communication with the FDA, and this issue will be closely reviewed and monitored," the company said.

From: http://www.guardian.co.uk/world/feedarticle/9454172

If You Prefer Natural Healing...